10x Genomics (TXG) Stock: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$75.59
4.13 (5.78%)
▲
5d:
+3.41%
30d:
-6.33%
90d:
+57.28%
BUY
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TXG shows positive signals but monitor for confirmation. Market pricing in 74.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: TXG shows positive signals but monitor for confirmation. Market pricing in 74.4% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $75.59, which is considered fair relative to its 30-day fair value range of $71.62 to $86.87. From a valuation perspective, the stock is trading at a premium (Forward PE: 985.5) compared to its historical average (185.8). At these levels, the market is pricing in 74.4% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $67.52, while resistance sits at $85.12. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: TXG scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $67.52, while resistance sits at $85.12. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: TXG scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$71.62 -
$86.87
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (62/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- NEUTRAL: Near Wall St target ($77.00)
- BEARISH: Market expects 74.4% growth - appears too optimistic based on history
- BULLISH: Bottoming setup score 62/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$71.62 -
$86.87
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$67.52
Resistance Level
$85.12
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
985.53
Wall Street Target
$77.00
(+1.9%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-12.2%
Valuation Premium vs History
+74.4% premium
PE vs Historical
985.5 vs 185.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+74.4%
(market-implied from PE analysis)
1-Year Target
$113.39
(+50%)
2-Year Target
$170.08
(+125%)
3-Year Target
$255.12
(+238%)
3-Yr Target (if PE normalizes)
(PE: 986→186)
PE COMPRESSION
$48.10
(-36%)
Significant PE compression expected
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 985.5, Growth: 109.0%)
$255.12
(+238%)
Base:
(SPY PE: 19.9, Growth: 109.0%)
$5.14
(-93%)
Bear:
(PE: 16.9, Growth: 109.0%)
$4.37
(-94%)
Share & Embed Analysis
Last updated: October 22, 2026 3:23 AM ET
Data refreshes hourly during market hours. Next update: 4:23 AM
Data refreshes hourly during market hours. Next update: 4:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 53 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
Advanced TXG Option Strategies
Professional options setups generated by AI based on today's TXG price and gamma walls.
